9065Background: CD73 dephosphorylates and converts extracellular adenosine monophosphate to adenosine, leading to immune escape of malignancies. Although epidermal growth factor receptor (EGFR) mutation-positive NSCLC showed high expression of CD73, the predictive relevance of CD73 expression in patients with EGFR mutation received immune checkpoint inhibitors (ICIs) is unknown. Methods: We screened 67 patients with Stage I-III EGFR mutation-positive NSCLC received complete resection (cohort A), 17 patients with advanced or recurrent NSCLC received immune checkpoint inhibitors after resistance to EGFR-TKI treatment (cohort B), and 31 patients with EGFR mutation-negative NSCLC treated with ICIs. CD73 expression was evaluated by immunohistochemical analysis, and tumors with staining in over 50% of tumor cells were scored as high expression. Results: In cohort A, the high CD73 expression group showed relatively shorter disease-free survival and overall survival than the low CD73 group in patients with Stage ...